Literature DB >> 17094416

Prognostic significance of intracellular laminin and Her2/neu overexpression in non-small cell lung cancer.

Jolanta Szelachowska1, Michal Jelen, Jan Kornafel.   

Abstract

UNLABELLED: This study was designed to test the hypothesis that Her2/neu expression, the level of intracellular laminin and Ki-67 index are of prognostic importance in patients with non-small cell lung cancer (NSCLC). The second aim of the study was to analyse the efficiency of post-operative radiotherapy in the group of patients treated at our hospital.
MATERIALS AND METHODS: Tumor tissue samples were obtained from 64 patients with primary NSCLC, who were operated on and post-operatively irradiated. Immunohistochemical analyses were performed on paraffin blocks of resected lung tissue. Survival of the patients was calculated on the basis of 5-year follow up.
RESULTS: From among the analysed factors only the enhanced expression of intracellular laminin, histological grade 3, adenocarcinoma type of cancer and statistically important radiotherapy parameters influenced patient survival. The influence of Her2/neu expression on survival almost reached statistical significance. In multivariate Cox analyses only the level of the intracellular laminin, overexpression of Her2/neu and dose time ratio (DTR) were found to be the independent risk factors for patients survival.
CONCLUSION: Enhanced expression of intracellular laminin, Her2/neu overexpression and interruptions during post-operative radiotherapy are detrimental for survival in patients with NSCLC.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17094416

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  4 in total

1.  Expression and association of HER2 with prognosis in early-stage (T1-T2N0M0) non-small cell lung cancer.

Authors:  Qing Xia; Zhihua Zhu; Jian Wang; Dongrong Situ; Ningning Zhou; Wenqi Jang
Journal:  Tumour Biol       Date:  2012-06-27

2.  Clinical significance of serum laminin levels in patients with lung cancer.

Authors:  Faruk Tas; Elif Bilgin; Didem Tastekin; Kayhan Erturk; Derya Duranyildiz
Journal:  Biomed Rep       Date:  2016-02-24

3.  Clinical significance and prognostic value of serum sHER-2/neu levels in patients with solid tumors.

Authors:  C Papila; H Uzun; H Balci; H Zerdali; C Sezgin; Günay Can; H Yanardag
Journal:  Med Oncol       Date:  2008-10-15       Impact factor: 3.064

Review 4.  Lung cancer-associated tumor antigens and the present status of immunotherapy against non-small-cell lung cancer.

Authors:  Kosei Yasumoto; Takeshi Hanagiri; Mitsuhiro Takenoyama
Journal:  Gen Thorac Cardiovasc Surg       Date:  2009-09-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.